Grethe Nørskov Rasmussen
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Dr. Grethe Nørskov Rasmussen is a Chief Development Officer at FluoGuide A/S.
Dr. Rasmussen was previously employed as a Senior Vice President-Product Development by Ascendis Pharma A/S, a Vice President-Protein Science by Maxygen, Inc., and a Principal by Novo Nordisk A/S.
She received her doctorate degree from Technical University of Denmark.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FLUOGUIDE A/S 2,1% | 31-12-2024 | 343.185 ( 2,1% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| FLUOGUIDE A/S | Corporate Officer/Principal | 01-01-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 01-01-2019 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
FluoGuide A/S
FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau